Boson COVID-19 Rapid Antigen Test


Purchasing Options: Box - 20

Quantity Limit Reached

  • The Boson Antigen Rapid Test is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal secretion samples.

    In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test. 

    Antigens are generally detectable in nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but other diagnostic information is necessary to determine infection status.

    Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.

    Accessible, large-scale testing helps contain the virus spread.  It is the perfect screening tool for organizations that want to protect their workplace from the risk of COVID-19 transmission.

    The Rapid SARS-CoV-2 Antigen Test Card is intended for use by trained clinical laboratory personnel specifically instructed and trained in vitro diagnostic procedures.

    The Boson COVID-19 Antigen Rapid Test Device is a Health Canada authorized COVID-19 testing device.

    Boson Rapid SARS-CoV-2 Antigen Test Instructional Card
    Boson Rapid SARS-CoV-2 Antigen Test Device Overview

    2022-01-23 Boson Rapid Test Deck

  • Easily deployed at a large scale

    Can be used in a wide variety of non-laboratory settings

    No special/additional instruments required

    Self-contained tube with "break off" swab minimizes staff exposure

    Extraction tube is fully enclosed for disposal 

    For more information about antigen testing devices, please visit the Health Canada website here. 

    • Test time: 15 minutes
    • Test Technology: Antigen 
    • Shelf Life (expiration): 18 months 
    • Quantity: 20 tests/kit
    • Diagnostic Sensitivity: 93.75%
    • Diagnostic Specificity: 98.4%
    • Sample Collection: Nasopharyngeal swab


    Test Kit Contains: 

    • 20 x Test Cassettes
    • 2 x 4ml Bottles of Sample Extraction Buffer Liquid
    • 20 x Sterilized Nasopharyngeal Swabs
    • 20 x Extraction Tubes (with lids attached)
    • 1 x Test Instructions for Use
  • Information, regulations, and guidance around the use of rapid antigen testing devices in Canada is frequently changing. While The Safe Direct website is updated often, we recommend referring to the Health Canada website for the most up to date information on:

    Interim guidance on the use of rapid antigen detection tests for the identification of SARS-CoV-2 infection

    Overview of Testing Devices for COVID-19

    Antigen Testing Devices

    Point-of-care and self-testing devices

    Test Swabs

    List of Authorized Testing Devices

  • Safe Direct offers wholesale and bulk pricing discounts for select larger order quantities. To find out if your order qualifies for a bulk pricing discount, please submit a wholesale order inquiry for a custom quote.

You may also like